Detalhe da pesquisa
1.
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study.
Eur J Endocrinol
; 173(3): 313-23, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26047625
2.
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Endocr Relat Cancer
; 22(5): 745-57, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26187128
3.
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Lancet Diabetes Endocrinol
; 2(11): 875-84, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25260838